CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup.
| Image |  |
|---|---|
| Description | scientific article published on July 2002 |
| Author/s |
author: Hani Gabra |
| Publication date | July 1, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |